These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21346557)

  • 21. Should patients with venous thromboembolism be screened for thrombophilia?
    Dalen JE
    Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited thrombophilia in arterial disease: a selective review.
    de Moerloose P; Boehlen F
    Semin Hematol; 2007 Apr; 44(2):106-13. PubMed ID: 17433903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuria.
    Emadi A; Streiff M
    Arch Iran Med; 2011 Nov; 14(6):401-11. PubMed ID: 22039845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
    Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
    Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of direct oral anticoagulants in inherited thrombophilia.
    Skelley JW; White CW; Thomason AR
    J Thromb Thrombolysis; 2017 Jan; 43(1):24-30. PubMed ID: 27734187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombolytic, antiplatelet and anticoagulant therapy for thrombotic disorders].
    Homma S; Yamaguchi I
    Nihon Rinsho; 1999 Jul; 57(7):1561-8. PubMed ID: 10429458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report.
    Das S; Karachiwala H; Cherian SV; Garcha AS; Jasti S; Gajra A
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):746-8. PubMed ID: 21885951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hereditary and acquired thrombophilic disorders.
    Baker WF; Bick RL
    Semin Thromb Hemost; 1999; 25(4):387-406. PubMed ID: 10548072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
    Higginbotham EA; Zimmerman SA; Howard TA; Schanberg L; Kredich D; Ware RE
    J Rheumatol; 2001 Feb; 28(2):370-2. PubMed ID: 11246680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular mechanisms of the therapeutic agents for kidney diseases: Anti-platelets/anti-coagulant medicines].
    Maruyama I
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():652-6. PubMed ID: 16523971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.